| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Verona Pharma PLC
13G/A
Amendment 2
VRNA · 925050106
|
1.2% |
11/14/2025
Event 9/30/2025
|
|||
|
Amdocs Limited
13G/A
Amendment 11
DOX · G02602103
|
2.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 3
EWTX · 28036F105
|
4.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Inspired Entertainment, Inc.
13G/A
Amendment 2
INSE · 45782N108
|
4.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 3
JANX · 47103J105
|
10.0% |
11/7/2025
Event 10/31/2025
|
|||
|
Enanta Pharmaceuticals, Inc.
13G
ENTA · 29251M106
|
12.1% |
11/7/2025
Event 10/31/2025
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.6% | ||||
|
89bio, Inc.
13G/A
Amendment 8
ETNB · 282559103
|
3.6% |
10/7/2025
Event 9/30/2025
|
|||
|
Invivyd, Inc.
13G
IVVD · 00534A102
|
11.6% |
9/8/2025
Event 8/29/2025
|
|||
|
VistaGen Therapeutics, Inc.
13G
VTGN · 92840H400
|
13.6% |
9/8/2025
Event 8/29/2025
|
|||
| Janus Henderson Group PLC | 13.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 11.7% | ||||
|
Benitec Biopharma Inc.
13G/A
Amendment 9
BNTC · 08205P209
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Maze Therapeutics, Inc.
13G/A
Amendment 1
MAZE · 578784100
|
6.0% |
8/14/2025
Event 3/31/2025
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 5
LXEO · 52886X107
|
11.1% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.2% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 2
FBRX · 34962G208
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 9.9% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.9% | ||||
|
Benitec Biopharma Inc.
13G/A
Amendment 8
BNTC · 08205P209
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Inspired Entertainment, Inc.
13G/A
Amendment 1
INSE · 45782N108
|
5.0% |
8/14/2025
Event 6/30/2025
|
|||
|
Amdocs Limited
13G/A
Amendment 10
DOX · G02602103
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 2
EWTX · 28036F105
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
|
Tyra Biosciences, Inc.
13G/A
Amendment 1
TYRA · 90240B106
|
5.4% |
8/14/2025
Event 6/30/2025
|
|||
|
Sensient Technologies Corporation
13G/A
Amendment 11
SXT · 81725T100
|
5.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 8
LGND · 53220K504
|
5.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Rentokil Initial PLC
13G/A
Amendment 3
RKLIF · G7494G105
|
5.7% |
8/14/2025
Event 6/30/2025
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 2
RVMD · 76155X100
|
5.7% |
8/14/2025
Event 6/30/2025
|
|||
|
OSI Systems, Inc.
13G/A
Amendment 11
OSIS · 671044105
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
|
Ardelyx, Inc.
13G/A
Amendment 7
ARDX · 039697107
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
|
Asure Software Inc
13G/A
Amendment 3
ASUR · 04649U102
|
6.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 6.3% | ||||
| Janus Henderson Venture Fund | 5.9% | ||||
|
Gildan Activewear Inc
13G/A
Amendment 1
GIL · 375916103
|
6.6% |
8/14/2025
Event 6/30/2025
|
|||
|
SS&C Technologies Holdings, Inc
13G/A
Amendment 11
SSNC · 78467J100
|
6.7% |
8/14/2025
Event 6/30/2025
|
|||
|
Sensata Technologies Holding PLC
13G/A
Amendment 10
ST · G8060N102
|
6.8% |
8/14/2025
Event 6/30/2025
|
|||
|
Aramark
13G/A
Amendment 3
ARMK · 03852U106
|
6.9% |
8/14/2025
Event 6/30/2025
|
|||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 4
IDYA · 45166A102
|
6.9% |
8/14/2025
Event 6/30/2025
|
|||
|
Flex Ltd.
13G/A
Amendment 5
FLEX · Y2573F102
|
7.1% |
8/14/2025
Event 6/30/2025
|
|||
|
Verona Pharma PLC
13G/A
Amendment 1
VRNA · 925050106
|
7.2% |
8/14/2025
Event 6/30/2025
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 2
JANX · 47103J105
|
7.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Structure Therapeutics Inc.
13G/A
Amendment 3
GPCR · 86366E106
|
8.0% |
8/14/2025
Event 6/30/2025
|
|||
|
Akero Therapeutics, Inc.
13G/A
Amendment 10
AKRO · 00973Y108
|
8.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Ziff Davis, Inc.
13G/A
Amendment 6
ZD · 48123V102
|
8.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Teleflex Incorporated
13G/A
Amendment 5
TFX · 879369106
|
9.4% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 9.4% | ||||
| Janus Henderson Enterprise Fund | 6.5% | ||||
|
Madrigal Pharmaceuticals, Inc.
13G/A
Amendment 6
MDGL · 558868105
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
|
Lantheus Holdings, Inc.
13G/A
Amendment 4
LNTH · 516544103
|
10.0% |
8/14/2025
Event 6/30/2025
|
|||
|
ICU Medical, Inc.
13G/A
Amendment 11
ICUI · 44930G107
|
10.0% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Enterprise Fund | 5.0% | ||||
|
Liberty Media Corporation
13G/A
Amendment 9
FWONK · 531229755
|
6.1% |
8/14/2025
Event 6/30/2025
|
|||
|
Soleno Therapeutics, Inc.
13G/A
Amendment 6
SLNO · 834203309
|
10.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 5
MIRM · 604749101
|
10.6% |
8/14/2025
Event 6/30/2025
|
|||
|
Protara Therapeutics, Inc.
13G/A
Amendment 3
TARA · 74365U107
|
10.6% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 10.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.1% | ||||
|
Mereo Biopharma Group PLC
13G/A
Amendment 5
MREO · 589492107
|
11.1% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.6% | ||||
|
WEX, Inc.
13G/A
Amendment 12
WEX · 96208T104
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Enterprise Fund | 7.3% | ||||
|
Vaxcyte, Inc.
13G/A
Amendment 7
PCVX · 92243G108
|
11.4% |
8/14/2025
Event 6/30/2025
|
|||
|
Avadel Pharmaceuticals plc
13G/A
Amendment 5
AVDL · G29687103
|
11.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Praxis Precision Medicines, Inc
13G/A
Amendment 2
PRAX · 74006W207
|
12.4% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 12.4% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.8% | ||||
|
Consensus Cloud Solutions, Inc.
13G/A
Amendment 6
CCSI · 20848V105
|
12.9% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 12.9% | ||||
| Janus Henderson Triton Fund | 7.0% | ||||
|
Cimpress PLC
13G/A
Amendment 13
CMPR · G2143T103
|
13.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 13.3% | ||||
| Janus Henderson Enterprise Fund | 9.5% | ||||
|
89bio, Inc.
13G/A
Amendment 7
ETNB · 282559103
|
14.2% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 14.2% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.1% | ||||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 2
DRUG · 10919W405
|
16.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 16.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 14.0% | ||||
|
Monopar Therapeutics Inc.
13G/A
Amendment 3
MNPR · 61023L207
|
19.2% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 19.2% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 16.5% | ||||
|
Ascendis Pharma A/S
13G/A
Amendment 7
ASND · 04351P101
|
8.0% |
8/14/2025
Event 6/30/2025
|
|||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 4
TENX · 88032L605
|
4.0% |
8/14/2025
Event 6/30/2025
|
|||
|
Larimar Therapeutics, Inc.
13G/A
Amendment 5
LRMR · 517125100
|
0% |
8/14/2025
Event 3/31/2025
|
|||
|
OmniAb, Inc.
13G/A
Amendment 4
OABI · 68218J103
|
0.8% |
8/14/2025
Event 6/30/2025
|
|||
|
Entrada Therapeutics, Inc.
13G/A
Amendment 2
TRDA · 29384C108
|
4.0% |
8/14/2025
Event 6/30/2025
|
|||
|
The Beauty Health Company
13G/A
Amendment 7
SKIN · 88331L108
|
4.5% |
8/14/2025
Event 6/30/2025
|
|||
|
Walker & Dunlop, Inc
13G/A
Amendment 7
WD · 93148P102
|
4.6% |
8/14/2025
Event 6/30/2025
|
|||
|
Biohaven Ltd.
13G/A
Amendment 5
BHVN · G1110E107
|
4.9% |
8/14/2025
Event 6/30/2025
|
|||
|
Dayforce, Inc.
13G
DAY · 15677J108
|
5.2% |
8/14/2025
Event 3/31/2025
|
|||
|
Revvity, Inc.
13G
RVTY · 714046109
|
6.1% |
8/14/2025
Event 3/31/2025
|
|||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 3
DYN · 26818M108
|
10.1% |
8/7/2025
Event 7/31/2025
|
|||
|
Avidity Biosciences, Inc.
13G/A
Amendment 2
RNAM · 05370A108
|
10.1% |
8/7/2025
Event 7/31/2025
|
|||
|
Travere Therapeutics, Inc.
13G/A
Amendment 1
TVTX · 89422G107
|
12.8% |
8/7/2025
Event 7/31/2025
|
|||
|
Surgery Partners, Inc.
13G/A
Amendment 2
SGRY · 86881A100
|
10.1% |
7/7/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 10.1% | ||||
| Janus Henderson Contrarian Fund | 9.1% | ||||
|
Praxis Precision Medicines, Inc
13G/A
Amendment 1
PRAX · 74006W207
|
11.3% |
6/6/2025
Event 5/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.5% | ||||
|
Lantheus Holdings, Inc.
13G/A
Amendment 4
LNTH · 516544103
|
10.1% |
6/6/2025
Event 5/30/2025
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 5
MIRM · 604749101
|
10.3% |
6/6/2025
Event 5/30/2025
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 4
MIRM · 604749101
|
9.7% |
5/15/2025
Event 3/31/2025
|
|||
|
Mereo Biopharma Group PLC
13G/A
Amendment 4
MREO · 589492107
|
14.3% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 14.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 12.7% | ||||
|
Teleflex Incorporated
13G/A
Amendment 4
TFX · 879369106
|
9.7% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 9.7% | ||||
| Janus Henderson Enterprise Fund | 6.5% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 3
TENX · 88032L605
|
9.9% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 9.9% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.9% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 1
FBRX · 34962G208
|
9.9% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 9.9% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.9% | ||||
|
Benitec Biopharma Inc.
13G/A
Amendment 7
BNTC · 08205P209
|
11.4% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 11.4% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Sensata Technologies Holding PLC
13G/A
Amendment 9
ST · G8060N102
|
6.6% |
5/14/2025
Event 3/31/2025
|
|||
|
Structure Therapeutics Inc.
13G/A
Amendment 2
GPCR · 86366E106
|
7.6% |
5/14/2025
Event 3/31/2025
|
|||
|
OmniAb, Inc.
13G/A
Amendment 3
OABI · 68218J103
|
6.6% |
5/14/2025
Event 3/31/2025
|
|||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 7
LGND · 53220K504
|
5.3% |
5/14/2025
Event 3/31/2025
|
|||
|
Sensient Technologies Corporation
13G/A
Amendment 10
SXT · 81725T100
|
5.4% |
5/14/2025
Event 3/31/2025
|
|||
|
Rentokil Initial PLC
13G/A
Amendment 2
RKLIF · G7494G105
|
5.4% |
5/14/2025
Event 3/31/2025
|
|||
|
Walker & Dunlop, Inc
13G/A
Amendment 6
WD · 93148P102
|
5.5% |
5/14/2025
Event 3/31/2025
|
|||
|
Revolution Medicines, Inc.
13G/A
Amendment 1
RVMD · 76155X100
|
5.5% |
5/14/2025
Event 3/31/2025
|
|||
|
Edgewise Therapeutics, Inc.
13G/A
Amendment 1
EWTX · 28036F105
|
5.6% |
5/14/2025
Event 3/31/2025
|
|||
|
Entrada Therapeutics, Inc.
13G/A
Amendment 1
TRDA · 29384C108
|
5.6% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 5.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.0% | ||||
|
Amdocs Limited
13G/A
Amendment 9
DOX · G02602103
|
6.0% |
5/14/2025
Event 3/31/2025
|
|||
|
Globus Medical, Inc.
13G/A
Amendment 7
GMED · 379577208
|
6.1% |
5/14/2025
Event 3/31/2025
|
|||
|
Aramark
13G/A
Amendment 2
ARMK · 03852U106
|
6.2% |
5/14/2025
Event 3/31/2025
|
|||
|
Biohaven Ltd.
13G/A
Amendment 4
BHVN · G1110E107
|
6.3% |
5/14/2025
Event 3/31/2025
|
|||
|
Asure Software Inc
13G/A
Amendment 2
ASUR · 04649U102
|
6.4% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 6.4% | ||||
| Janus Henderson Venture Fund | 6.0% | ||||
|
SS&C Technologies Holdings, Inc
13G/A
Amendment 10
SSNC · 78467J100
|
6.6% |
5/14/2025
Event 3/31/2025
|
|||
|
Flex Ltd.
13G/A
Amendment 4
FLEX · Y2573F102
|
6.9% |
5/14/2025
Event 3/31/2025
|
|||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 3
IDYA · 45166A102
|
7.3% |
5/14/2025
Event 3/31/2025
|
|||
|
OSI Systems, Inc.
13G/A
Amendment 10
OSIS · 671044105
|
7.4% |
5/14/2025
Event 3/31/2025
|
|||
|
Janux Therapeutics, Inc.
13G/A
Amendment 1
JANX · 47103J105
|
7.8% |
5/14/2025
Event 3/31/2025
|
|||
|
Ziff Davis, Inc.
13G/A
Amendment 5
ZD · 48123V102
|
8.3% |
5/14/2025
Event 3/31/2025
|
|||
|
Larimar Therapeutics, Inc.
13G/A
Amendment 4
LRMR · 517125100
|
8.7% |
5/14/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 8.7% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.1% | ||||
|
Akero Therapeutics, Inc.
13G/A
Amendment 9
AKRO · 00973Y108
|
8.9% |
5/14/2025
Event 3/31/2025
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.